Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis
Frontiers in Oncology, 2022 Malignant pleural mesothelioma is an uncommon aggressive tumor. Its incidence is even lower when the lung parenchyma is the primary site. Myositis is a common paraneoplastic syndrome, but it rarely presents with malignant pleural mesothelioma.
Dandan Gong, Jian Yu, Xiaodong Jiang
doaj +1 more source
Immunotherapy in Malignant Pleural Mesothelioma [PDF]
Frontiers in Oncology, 2020 The only registered systemic treatment for malignant pleural mesothelioma (MPM) is platinum based chemotherapy combined with pemetrexed, with or without bevacizumab. Immunotherapy did seem active in small phase II trials. In this review, we will highlight the most important immunotherapy-based research performed and put a focus on the future of MPM. PD-
Gooijer, C.J. de +3 more
openaire +4 more sources
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
Thoracic Cancer, 2020 Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi +6 more
doaj +1 more source
Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma
Case Reports in Nephrology, 2022 Malignant pleural mesothelioma is rarely associated with nephrotic syndrome. Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms.
Kei Nagai +3 more
doaj +1 more source
Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. [PDF]
, 2017 Malignant mesothelioma is a rare cancer that arises from the mesothelial cells that line the pleural cavity and less commonly from the peritoneal lining of the abdomen and pelvis.
Bastian, Boris C +10 more
core +2 more sources
Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma
Egyptian Journal of Chest Disease and Tuberculosis, 2015 Aim of the work: To evaluate the role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma by detecting its level in the pleural fluid and serum of the patient with malignant pleural mesothelioma in comparison with other causes of ...
Rehab El Sayed +4 more
doaj +1 more source
Can malignant and inflammatory pleural effusions in dogs be distinguished using computed tomography [PDF]
, 2017 Computed tomography (CT) is the primary imaging modality used to investigate human patients with suspected malignant or inflammatory pleural effusion, but there is a lack of information about the clinical use of this test in dogs.
Aquino +35 more
core +2 more sources
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
European Respiratory Review, 2016 Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the ...
Anna C. Bibby +7 more
doaj +1 more source
Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines [PDF]
, 2015 Malignant mesothelioma is rare and difficult to diagnose. Its identification depends upon pathological investigation (cyto-histological assessment and immunohistochemistry) supported by clinical and radiological evidence.
Ascoli, Valeria
core +2 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2022 Context Malignant mesothelioma is an insidious neoplasm, with malignant pleural mesothelioma as the most common type, which is characterized by poor prognosis in most patients owing to late presentation. The use of noninvasive markers for early diagnosis
Mona M Ahmed +3 more
doaj +1 more source